Care Coordination for Prisoners
(Call2Care Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue them, especially since the trial involves people with chronic conditions who are currently taking prescription medications.
What data supports the effectiveness of the treatment Calls and Coordination for Transitions of Care At Re-entry?
Research shows that coordinated care programs, like the Transitions Clinic Network, help people leaving prison connect with healthcare services, improving their health outcomes. These programs use community health workers and data sharing to ensure continuous care, which is crucial for managing chronic conditions and reducing emergency care visits.12345
Is the care coordination program for prisoners safe for humans?
How does the treatment in the Care Coordination for Prisoners trial differ from other treatments for this condition?
This treatment is unique because it focuses on improving care coordination for prisoners transitioning back into the community, addressing the gap in healthcare continuity that often leads to poor health outcomes. Unlike standard treatments that may focus solely on medical interventions, this approach emphasizes collaboration between correctional facilities and community healthcare systems to ensure a seamless transition and ongoing support for released individuals.34578
What is the purpose of this trial?
The goal of this clinical trial is to learn if a short program for people being released from prison can help connect them to medical care. The main question it aims to answer is:* Will there be more non-emergency, outpatient clinic visits?Researchers will compare the number of clinic visits between people who use a Nurse Case Manager (NCM) to people in enhanced usual care.Participants will:* Complete surveys* Talk to a study team member 2-3 times, or talk to a study team member 2-3 times and talk to an NCM 6-11 times
Research Team
Marguerite Burns
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for individuals recently released from prison who have Aviator's Disease, Substance Use Disorder, chronic illnesses, or mental illness. They should not be currently enrolled in similar programs and must be willing to complete surveys and engage with the study team.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-release Preparation
Participants are enrolled and prepared for the transitional care program before release from prison
Transitional Care Intervention
Participants receive weekly phone calls and texts for up to 60 days post-release to connect them to primary care
Follow-up
Participants are monitored for the number of emergency and non-emergency clinic visits
Treatment Details
Interventions
- Calls and Coordination for Transitions of Care At Re-entry
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator